Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?

Epidemiology and Data Science (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	668-669
Journal	Annals of Internal Medicine
Volume	151
Issue number	9
DOIs	https://doi.org/10.7326/0003-4819-151-9-200911030-00013
Publication status	Published - 2009

Access to Document

https://doi.org/10.7326/0003-4819-151-9-200911030-00013

Cite this

@article{3b771cec1e8f4d8f83306eed9e8b92b5,

title = "Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?",

author = "M. Boers",

year = "2009",

doi = "https://doi.org/10.7326/0003-4819-151-9-200911030-00013",

language = "Undefined/Unknown",

volume = "151",

pages = "668--669",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "9",

}

TY - JOUR

T1 - Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?

AU - Boers, M.

PY - 2009

Y1 - 2009

U2 - https://doi.org/10.7326/0003-4819-151-9-200911030-00013

DO - https://doi.org/10.7326/0003-4819-151-9-200911030-00013

M3 - Article

C2 - 19884628

SN - 0003-4819

VL - 151

SP - 668

EP - 669

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 9

ER -